HBL Hadasit Bio Holdings Ltd
TASE:HDST
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hangzhou Honghua Digital Technology Stock Co Ltd
SSE:688789
|
CN |
|
K
|
Kinross Gold Corp
NYSE:KGC
|
CA |
HBL Hadasit Bio Holdings Ltd
EPS (Diluted)
HBL Hadasit Bio Holdings Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
HBL Hadasit Bio Holdings Ltd
TASE:HDST
|
EPS (Diluted)
-₪2
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
EPS (Diluted)
$0
|
CAGR 3-Years
29%
|
CAGR 5-Years
4%
|
CAGR 10-Years
35%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
EPS (Diluted)
-$3
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
EPS (Diluted)
$0
|
CAGR 3-Years
-12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
EPS (Diluted)
-$2
|
CAGR 3-Years
29%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
HBL Hadasit Bio Holdings Ltd
Glance View
HBL- Hadasit Bio-Holdings Ltd. engages in investments in research and development companies in the medical and biotechnology sectors. The Company’s subsidiaries enable research and development and promote intellectual property (IP) to the medical and biotechnological industries. The firm together with its strategic partners, has established a number of start-up companies, and is assigned to commercialize that IP either through granting a product license to biotechnological or pharmaceutical companies or via the creation of a subsidiary which operates in the premise of HMO. Hadasit is equipped with resources and capabilities required for composing and conducting the pre-clinical services and clinical studies, establishing start-up companies, offering product licensing and providing international consulting services. The Company’s framework serves to address investment in early-stage biotechnological star-ups, by distributing both risk and success amongst a number of companies.
See Also
What is HBL Hadasit Bio Holdings Ltd's EPS (Diluted)?
EPS (Diluted)
-2.8
ILS
Based on the financial report for Dec 31, 2022, HBL Hadasit Bio Holdings Ltd's EPS (Diluted) amounts to -2.8 ILS.
What is HBL Hadasit Bio Holdings Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-11%
The average annual EPS (Diluted) growth rates for HBL Hadasit Bio Holdings Ltd have been -11% over the past three years .
